友芝友生物－Ｂ
港股 02496正常交易YZYBIO-B
Wuhan YZY Biopharma Co Ltd is a China-based company principally engaged in the research, development, production and sales of pharmaceuticals. The Company is mainly engaged in the research, development and industrialization of bispecific antibody drugs. The Company's main products include anti-PD1&anti-CD3, anti-CD19&anti-CD3, and anti-CDX&CD3. The Company's drug products are mainly used in major diseases such as tumor, immunity, inflammation, cardiovascular and infection.
3.68 HKD
▲ 0.00%更新于 2026-08-04 16:00:05（北京时间）
行情来源：新浪财经
- 行业
- —
- 交易所/板块
- 主板
- CIK（SEC）
- —
- 上市日期
- 2023-09-25
- 事件总数
- 142
- 最新事件
- 2026-08-05
- 主席
- Zhou Pengfei
- 公司总部
- 香港铜锣湾希慎道33号利园一期19楼1915室
- 公司网址
- www.yzybio.com
公司档案来源：港交所披露易（公告）· 新浪财经（行情/公司资料）
动态监测
持续跟踪最新公告、活跃度与高信号事件。
事件类型
显示 142 / 142 条